BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 8313486)

  • 1. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of "once-a-month" combined injectable contraceptives.
    Newton JR; D'arcangues C; Hall PE
    J Obstet Gynaecol (Lahore); 1994; 4 Suppl 1():S1-34. PubMed ID: 12290848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
    Hassan EO; el-Nahal N; el-Hussein M
    Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-a-month injectable contraceptives.
    d'Arcangues C
    World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existing once-a-month combined injectable contraceptives.
    Toppozada MK
    Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
    el Nahal N; Hassan EO; el Houssinie M
    Contraception; 1999 Jun; 59(6):369-75. PubMed ID: 10518231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of cyclofem once-a-month injectable contraceptive in Mexico.
    Garza-Flores J; Moraks del Olmo A; Fuziwara JL; Figueroa JG; Alonso A; Monroy J; Perez M; Urbina-Fuentes M; Guevara SJ; Cedeno E; Barrios R; Ferman JJ; Medina LM; Velazquez E; Perez-Palacios G
    Contraception; 1998 Jul; 58(1):7-12. PubMed ID: 9743890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-a-month estrogen/progestogen injectables.
    D'arcangues C
    Entre Nous Cph Den; 1991 Dec; (19):15. PubMed ID: 12222332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
    Seibert B; Günzel P
    Contraception; 1994 Apr; 49(4):303-33. PubMed ID: 8013217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
    Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera.
    Hall PE
    Int J Gynaecol Obstet; 1998 Aug; 62 Suppl 1():S43-56. PubMed ID: 9806239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
    Hassan EO; el-Nahal N; el-Hussinie M
    Contraception; 1999 Aug; 60(2):87-92. PubMed ID: 10592855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
    United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
    Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.